Bi-Jun Huang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

Cancer gene therapy

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ming-Dian Wang, Hui-Ting Li, Li-Xia Peng, Yan Mei, Li-Sheng Zheng, Chang-Zhi Li, Dong-Fang Meng, Yan-Hong Lang, Liang Xu, Xing-Si Peng, Zhi-Jie Liu, De-Huan Xie, Ling-Ling Guo, Mao-Guang Ma, Liu-Yan Ding, Bi-Jun Huang, Yun Cao, Chao-Nan Qian
TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling. Cancer gene therapy (2023)
Ming-Dian Wang, Hui-Ting Li, Li-Xia Peng, Yan Mei, Li-Sheng Zheng, Chang-Zhi Li, Dong-Fang Meng, Yan-Hong Lang, Liang Xu, Xing-Si Peng, Zhi-Jie Liu, De-Huan Xie, Ling-Ling Guo, Mao-Guang Ma, Liu-Yan Ding, Bi-Jun Huang, Yun Cao, Chao-Nan Qian
TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling. Cancer gene therapy 31 (3) (2023)
Ming-Dian Wang, Hui-Ting Li, Li-Xia Peng, Yan Mei, Li-Sheng Zheng, Chang-Zhi Li, Dong-Fang Meng, Yan-Hong Lang, Liang Xu, Xing-Si Peng, Zhi-Jie Liu, De-Huan Xie, Ling-Ling Guo, Mao-Guang Ma, Liu-Yan Ding, Bi-Jun Huang, Yun Cao, Chao-Nan Qian
TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling. Cancer gene therapy 31 (3) (2023)
Ming-Dian Wang, Hui-Ting Li, Li-Xia Peng, Yan Mei, Li-Sheng Zheng, Chang-Zhi Li, Dong-Fang Meng, Yan-Hong Lang, Liang Xu, Xing-Si Peng, Zhi-Jie Liu, De-Huan Xie, Ling-Ling Guo, Mao-Guang Ma, Liu-Yan Ding, Bi-Jun Huang, Yun Cao, Chao-Nan Qian
TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling. Cancer gene therapy 31 (3) (2023)
Jing Wang, Tie-Jun Huang, Yan Mei, Fei-Fei Luo, De-Huan Xie, Li-Xia Peng, Bao-Qi Liu, Mei-Ling Fan, Jiang-Bo Zhang, Shu-Tao Zheng, Chao-Nan Qian, Bi-Jun Huang
Novel long noncoding RNA LINC02820 augments TNF signaling pathway to remodel cytoskeleton and potentiate metastasis in esophageal squamous cell carcinoma. Cancer gene therapy (2022)
Zhan-Fei Zhang, Tie-Jun Huang, Xin-Ke Zhang, Yu-Jie Xie, Si-Ting Lin, Fei-Fei Luo, Dong-Fang Meng, Hao Hu, Jing Wang, Li-Xia Peng, Chao-Nan Qian, Chao Cheng, Bi-Jun Huang
AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway. Journal of cellular and molecular medicine 24 (17) (2020)

Bi-Jun Huang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bi-Jun Huang